While cancer research acknowledges XIST as a cancer-promoting gene due to its association with tumor occurrence and development via targeting of the tumor-suppressing miR-34a-5p and miR-137 (Wang et al., 2017; Sun et al., 2018). The gene discussed is XIST; the disease is cancer.